Denosumab May Prolong Metastasis-Free Survival In Men With High-Risk Prostate Cancer
5/18/2011
Data on the use of denosumab (Xgeva) to improve bone metastases-free survival in men with high-risk prostate cancer was presented at the American Urological Association conference today for the first time. If approved by the Food and Drug Administration (FDA), the use of denosumab injections will be the first successful treatment for bone metastasis prevention in prostate cancer...
Half Of Prostate Cancers Could Potentially Benefit From New Type Of Cancer Drugs, U-M Study Finds
5/18/2011
About half of prostate cancers have a genetic anomaly that appears to make tumor cells responsive to a new class of cancer-fighting drugs, a new study from the University of Michigan Comprehensive Cancer Center finds...
Genentech To Present Significant Progress In Advanced Skin, Lung And Ovarian Cancers At ASCO
5/18/2011
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that data showing new personalized approaches for people with skin and lung cancer, plus new data with Avastin® (bevacizumab) in ovarian cancer, will be presented at the 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)...
Hospital Discharges Indicate More Men May Require Surgery For BPH
5/18/2011
Despite an increased use of oral therapies to treat benign prostatic hyperplasia (BPH), some men may not be receiving treatment at the extent to which it is needed and may still suffer severe adverse complications as a result, according to new data from the University of California, San Diego (UCSD) being presented this week at the Annual Meeting of the American Urological Asso...
$700,000 Injected Into Childhood Cancer Research By The Cole Foundation
5/18/2011
Pediatric and young adult leukemia and lymphoma research in Quebec received a massive boost, following the Cole Foundation's announcement that it would provide more than $700,000 to be shared among 10 Universite de Montreal and four McGill University young scientists...
The male foreskin may be a reservoir for human papillomavirus (HPV), the virus that can lead to cervical cancer and genital warts, suggesting that boys - in addition to girls - should consider vaccination to prevent later transfer through sexual contact, according to researchers from Innsbruck Medical University in Austria...
Painful Prostate Condition May Be Relieved By Experimental Treatment
5/18/2011
New findings show that treatment with a specific alpha blocker helps reduce symptoms and improve quality of life for men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). The alpha-blocker, known as silodosin, works by selectively relaxing the muscles in the bladder neck and prostate...
Skin Cancer Awareness Month: Melanoma, Tanning Bed Ban War Wages On
5/18/2011
While May 2011 is Skin Cancer Awareness Month, the war rages on between those that want to tan naturally and unnaturally and the agency that is doing its damndest to save lives from overexposure to harmful UV rays that damage the skin's natural defense and can often lead to increased prevalence of killer melanoma. Melanoma is the most serious form of skin cancer...
Eribulin (Halaven(R)) is today approved for use in Switzerland by Swissmedic, the Swiss Agency for Therapeutic Products, as a monotherapy treatment of patients with locally advanced and metastatic breast carcinoma with progression after prior therapy with an anthracycline, a taxane and capecitabine...
The Risk Of Lethal Prostate Cancer May Be Reduced In Coffee Drinkers
5/18/2011
Men who regularly drink coffee appear to have a lower risk of developing a lethal form of prostate cancer, according to a new study led by Harvard School of Public Health (HSPH) researchers. What's more, the lower risk was evident among men who drank either regular or decaffeinated coffee...